Testing starch and a drug after stem cell transplant
Part of Blood & lymphatic, Cancer, Digestive system clinical trials.
This trial tests if adding a special starch and a drug called deferasirox can improve recovery for people who have a stem cell transplant for blood disorders. The starch may help with gut health and the drug reduces iron, which might help prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are getting a stem cell transplant from a fully matched donor (related or unrelated) after strong chemo or radiation
- You are 18 years or older
- You are in good physical function (able to do most daily activities)
- You are able to swallow pills
- You do not have active inflammatory bowel disease or have had gastric bypass surgery
- You do not have active C. diff infection or iron deficiency anemia needing treatment
- You are not already taking deferasirox for iron overload
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking probiotics made from your own and your donor's bacteria can help prevent or reduce gut problems (like diarrhea) after a stem cell transplant. It may help your intestines recover and feel better.
This study tests whether a high-fiber diet can help patients who are about to have a stem cell transplant. It aims to see if eating more fiber can improve recovery and overall health during and after the transplant.
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
This trial tests if a drug combo (cyclophosphamide, sirolimus, and ruxolitinib) works better than another combo (cyclophosphamide, sirolimus, and mycophenolate mofetil) to prevent graft versus host disease in people getting a stem cell transplant for certain blood cancers.
This study looks at blood sugar problems in people who have had a stem cell transplant from a donor. It may help doctors learn how to better manage or prevent diabetes after a transplant.
Hear when a new Allogeneic Stem Cell Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.